Major Declines Rock the U.S. Market on August 7, 2025
While the broader market showed mixed results, several individual stocks experienced significant sell-offs on August 7, 2025. The list of U.S. stock market losers was dominated by companies from the technology, healthcare, and consumer services sectors. Let’s take a closer look at today’s top decliners.
🔻 Top Stock Losers – August 7, 2025
| Ticker | Company Name | Closing Price | % Change | Sector |
|---|---|---|---|---|
| SMX | Security Matters Public Ltd. | $4.88 | −86.72% | Technology Services |
| RDW | Redwire Corporation | $9.47 | −30.88% | Electronic Technology |
| SEAT | Vivid Seats Inc. | $17.93 | −30.18% | Consumer Services |
| SANA | Sana Biotechnology, Inc. | $2.97 | −30.12% | Health Technology |
| CROX | Crocs, Inc. | $74.39 | −29.24% | Consumer Non-Durables |
| ECOR | electroCore, Inc. | $4.91 | −29.15% | Health Technology |
| BINI | Bollinger Innovations, Inc. | $2.14 | −27.95% | Technology Services |
| HAE | Haemonetics Corporation | $55.63 | −26.58% | Health Technology |
🚨 1. SMX (Security Matters Public Ltd) – −86.72%
SMX posted a massive 86.72% drop, closing at just $4.88. The crash was triggered by reports of regulatory issues and concerns over financial transparency. With low trading volume and a small market cap, investor sentiment quickly collapsed.
Despite the company’s potential in digital supply chain technology, today’s plunge reflects deep uncertainty about its future viability.
🛰️ 2. Redwire Corporation (RDW) – −30.88%
Redwire, a space infrastructure company, dropped 30.88% to close at $9.47. The sharp decline came after disappointing earnings, which missed both revenue and EPS estimates. Investor reaction was swift due to its elevated valuation and slower-than-expected growth in government contracts.
🎟️ 3. Vivid Seats Inc. (SEAT) – −30.18%
Vivid Seats, a major ticket resale platform, fell over 30% despite rising demand for live events. Analysts cited margin compression, high overhead costs, and weakening forward guidance as the main culprits.
The sell-off suggests investor skepticism over profitability in a crowded digital ticketing space.
🧬 4. Sana Biotechnology, Inc. (SANA) – −30.12%
Sana Biotechnology dropped to $2.97, shedding 30.12% in value. Although the company holds promise in cell and gene therapies, its latest clinical trial delay sparked investor concern.
The biotechnology sector is especially sensitive to delays and approvals, and SANA’s fall underscores the volatility that surrounds pre-revenue healthcare innovators.
👟 5. Crocs, Inc. (CROX) – −29.24%
Footwear giant Crocs slumped nearly 30% after issuing weak Q3 guidance. Although the company posted solid earnings, it warned of slowing consumer demand in North America and rising material costs.
This pullback signals broader concerns in the discretionary spending space as inflation pressures linger.
🧠 6. electroCore, Inc. (ECOR) – −29.15%
electroCore, a neurostimulation medical device firm, fell 29.15% to $4.91. The drop came after mixed clinical data and investor worry over slow product adoption. Although analysts remain cautiously optimistic, ECOR’s stock has remained highly speculative.
💡 7. Bollinger Innovations, Inc. (BINI) – −27.95%
BINI, a niche tech player, plunged 27.95% despite no major news. The sharp decline is likely due to profit-taking, high volatility, and previous speculative gains. The company’s reported financials show extreme loss figures, raising concerns among investors and regulators.
🩸 8. Haemonetics Corporation (HAE) – −26.58%
Haemonetics, a leader in blood and plasma management solutions, dropped nearly 27% after issuing subdued forward guidance and disclosing operational challenges in its North American division. Despite strong revenue in Europe, cost overruns and production issues weighed on the outlook.
